fig1

From: Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways

Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways

Figure 1. AR-independent mechanisms of resistance to new generation hormonal therapy and interaction with AR signalling. AR: androgen receptor; NE: neuroendocrine transformation; TKR: tyrosine kinase receptor; CDK: cyclin dependent kinase

Cancer Drug Resistance

ISSN 2578-532X (Online)

editorial@cdrjournal.com

Navigation

Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

partners@oaepublish.com

Discover Content

Strategic Collaborators

Follow OAE

Privacy Cookies Terms of Service